AXN LTD
Company number 08165678 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Financial Health Score: D+ (Guarded Condition)
AXN LTD is financially solvent but suffering from chronic, progressive decline and severe cash anemia. While the company does not have dangerously high liabilities, its vital organs—specifically cash flow and retained earnings—have been deteriorating for five consecutive years. The business is currently surviving on life support, relying almost entirely on a single, illiquid asset (a debtor) while generating virtually no active cash or revenue.
2. Key Vital Signs
- Cash Reserves (Blood Pressure): £516 — Dangerously low. Compared to its peak of £28,347 in 2019, the company's cash flow has effectively flatlined. A few unexpected expenses could cause a cardiac arrest in the business's day-to-day operations.
- Net Assets (Body Mass): £25,208 — Declining. The company’s overall net worth has plummeted from a healthy £146,442 in 2019 to just over £25k. This represents a steady, multi-year weight loss of over 80% of its total value.
- Retained Earnings (Nutritional Intake): £25,198 — Down from £27,758 the previous year. The drop of £2,560 indicates that the business operated at a loss this year. The company is consuming its own reserves to survive rather than generating new energy (profit).
- Debtors (Blocked Arteries): £25,202 — This represents 98% of the company's current assets. Having this much capital tied up in "Other Debtors" rather than cash or active trade is a major blockage. It suggests the money owed is either long-overdue, potentially irrecoverable, or a director's loan that has drained the company of its liquidity.
- Liabilities (Cholesterol): £510 — Very low. The company has virtually no debt, which is the one positive vital sign. It is not being crushed by external liabilities, but this is largely because the business appears to be dormant or operating at a micro-level with zero employees.
3. Diagnosis
Progressive Financial Atrophy with Severe Cash Anemia
The clinical picture is one of a business that has slowly wound down over the past five years. Following its peak health in 2019, AXN LTD has experienced a steady hemorrhage of value. The most alarming symptom is the composition of its current assets: with only £516 in the bank, the company is entirely dependent on collecting the £25,202 owed to it by debtors.
If this debtor balance is a loan to the director (Mr. Andrew Richards, who holds significant control), it indicates that the company's historical profits have been extracted, leaving the corporate shell severely anemic. If it is an external trade debtor, the collection risk is immense—why has it not been converted to cash? Furthermore, the complete depreciation of the company's motor vehicle and the total lack of trade creditors suggest that the core "environmental consulting" activity (formerly "Specialist Surveying Services") has ceased to operate as a going concern. The company is currently in a state of financial hibernation—alive, but not functioning.
4. Recommendations
- Clear the Blockage (Debt Collection): The immediate priority is converting the £25,202 debtor into cash. If this is an external debt, aggressive collection protocols must be initiated. If this represents a director's overdrawn loan account, a formal repayment schedule must be established to restore the company's liquidity.
- Assess Viability (Palliative Care vs. Recovery): With zero employees, no trade creditors, and a fully depreciated vehicle, the director must decide if AXN LTD still has a commercial purpose. If the consulting work has ceased, the most tax-efficient and administratively clean path may be to strike the company off the register and extract the remaining capital.
- Stop the Bleeding (Cost Control): Although liabilities are currently minimal, the retained earnings still dropped by over £2,500 this year. Investigate what is draining the P&L reserve when there is no visible trading activity and eliminate unnecessary overheads.
- Cash Transfusion: If the business is to continue, a capital injection or a new line of revenue is urgently required. £516 is insufficient to fund even the most basic operational expenses, leaving the company completely vulnerable to any unforeseen costs.